Insider · CIK 0001590157

Robbins Andrew R

Reports to the SEC for 4 companies · WALTHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001590157

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-19	COGTCogent Biosciences, Inc.G Gift	Director, President and CEO	GGift	+160K sh	—	—	160,000
2026-05-19	COGTCogent Biosciences, Inc.G Gift	Director, President and CEO	GGift	−160K sh	—	—	497,503
2025-12-17	COGTCogent Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+245K sh	—	—	245,000
2025-12-17	COGTCogent Biosciences, Inc.A Award	Director, President and CEO	AAward	+185K sh	—	—	185,000
2025-12-17	COGTCogent Biosciences, Inc.F Tax Payment	Director, President and CEO	FTax Payment	−367K sh	$39.45	−$14.5M	657,503
2025-12-17	COGTCogent Biosciences, Inc.A Award	Director, President and CEO	AAward	+840K sh	—	—	1,025,000
2025-01-23	COGTCogent Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+915K sh	—	—	915,000
2024-03-11	Harpoon Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−5,000 sh	—	—	0
2024-03-11	Harpoon Therapeutics, Inc.Director Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,300 sh	—	—	0
2024-03-11	Harpoon Therapeutics, Inc.Director Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,016 sh	—	—	0
2024-01-23	COGTCogent Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+1.1M sh	—	—	1,100,000
2023-11-27	Harpoon Therapeutics, Inc.A Award	Director	AAward	+5,000 sh	—	—	5,000
2023-06-22	Harpoon Therapeutics, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+23K sh	—	—	23,000
2023-02-13	COGTCogent Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+525K sh	—	—	525,000
2022-06-22	Harpoon Therapeutics, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+10.2K sh	—	—	10,167
2022-01-25	COGTCogent Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+690K sh	$4.94	+$3.41M	690,000
2021-05-04	Harpoon Therapeutics, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+10.2K sh	—	—	10,167
2021-05-04	Harpoon Therapeutics, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+10.2K sh	—	—	10,167
2021-02-10	COGTCogent Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+315K sh	—	—	315,200
2020-12-07	COGTCogent Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+457K sh	—	—	456,693
2020-10-23	COGTCogent Biosciences, Inc. · Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+7.44M sh	—	—	7,442,421
2020-03-30	Harpoon Therapeutics, Inc.Director Stock Option (right to buy)A Award	Director	AAward	+20.3K sh	—	—	20,335
2019-07-30	ARRAY BIOPHARMA INCStock Option (Right to Buy)D Disposition to Issuer	COO	DDisposition to Issuer	−236K sh	—	—	0
2019-07-30	ARRAY BIOPHARMA INCStock Option (Right to Buy)D Disposition to Issuer	COO	DDisposition to Issuer	−314K sh	—	—	0
2019-07-30	ARRAY BIOPHARMA INCStock Option (Right to Buy)D Disposition to Issuer	COO	DDisposition to Issuer	−335K sh	—	—	0
2019-07-30	ARRAY BIOPHARMA INCStock Option (Right to Buy)D Disposition to Issuer	COO	DDisposition to Issuer	−316K sh	—	—	0
2019-07-30	ARRAY BIOPHARMA INCStock Option (Right to Buy)D Disposition to Issuer	COO	DDisposition to Issuer	−236K sh	—	—	0
2019-07-30	ARRAY BIOPHARMA INCStock Option (Right to Buy)D Disposition to Issuer	COO	DDisposition to Issuer	−12.5K sh	—	—	0
2019-07-30	ARRAY BIOPHARMA INCD Disposition to Issuer	COO	DDisposition to Issuer	−131K sh	—	—	0
2019-07-30	ARRAY BIOPHARMA INCD Disposition to Issuer	COO	DDisposition to Issuer	−71K sh	$48.00	−$3.41M	130,542
2019-04-01	ARRAY BIOPHARMA INCM Exercise/Conversion	COO	MExercise/Conversion	+19.7K sh	—	—	79,682
2019-04-01	ARRAY BIOPHARMA INCF Tax Payment	COO	FTax Payment	−8,660 sh	$24.60	−$213K	71,022
2019-04-01	ARRAY BIOPHARMA INCRestricted Stock UnitsM Exercise/Conversion	COO	MExercise/Conversion	−9,844 sh	—	—	0
2019-04-01	ARRAY BIOPHARMA INCRestricted Stock UnitsM Exercise/Conversion	COO	MExercise/Conversion	−9,844 sh	—	—	9,844
2019-02-06	ARRAY BIOPHARMA INCS Sale	COO	SSale	−240K sh	$20.02	−$4.8M	59,994
2019-02-06	ARRAY BIOPHARMA INCStock Option (Right to Buy)M Exercise/Conversion	COO	MExercise/Conversion	−37.5K sh	—	—	12,500
2019-02-06	ARRAY BIOPHARMA INCStock Option (Right to Buy)M Exercise/Conversion	COO	MExercise/Conversion	−87.5K sh	—	—	0
2019-02-06	ARRAY BIOPHARMA INCM Exercise/Conversion	COO	MExercise/Conversion	+87.5K sh	$4.63	+$405K	299,620
2019-02-06	ARRAY BIOPHARMA INCM Exercise/Conversion	COO	MExercise/Conversion	+37.5K sh	$8.20	+$308K	212,120
2018-12-16	ARRAY BIOPHARMA INCRestricted Stock UnitsM Exercise/Conversion	COO	MExercise/Conversion	−14K sh	—	—	41,907
2018-12-16	ARRAY BIOPHARMA INCRestricted Stock UnitsM Exercise/Conversion	COO	MExercise/Conversion	−13.1K sh	—	—	26,166
2018-12-16	ARRAY BIOPHARMA INCF Tax Payment	COO	FTax Payment	−11.9K sh	$15.97	−$190K	174,620
2018-12-16	ARRAY BIOPHARMA INCM Exercise/Conversion	COO	MExercise/Conversion	+27.1K sh	—	—	186,518
2018-12-14	ARRAY BIOPHARMA INCRestricted Stock UnitsA Award	COO	AAward	+52.6K sh	—	—	52,625
2018-12-14	ARRAY BIOPHARMA INCStock Option (Right to Buy)A Award	COO	AAward	+316K sh	—	—	315,750
2018-06-27	ARRAY BIOPHARMA INCF Tax Payment	COO	FTax Payment	−14.1K sh	$18.50	−$261K	177,431
2018-06-27	ARRAY BIOPHARMA INCS Sale	COO	SSale	−18K sh	$17.74	−$319K	159,467
2018-06-27	ARRAY BIOPHARMA INCRestricted Stock UnitsM Exercise/Conversion	COO	MExercise/Conversion	−32.1K sh	—	—	0
2018-06-27	ARRAY BIOPHARMA INCM Exercise/Conversion	COO	MExercise/Conversion	+32.1K sh	—	—	191,535
2018-04-01	ARRAY BIOPHARMA INCRestricted Stock UnitsM Exercise/Conversion	COO	MExercise/Conversion	−9,844 sh	—	—	19,688

Recent filings

Accepted (ET)
May 214
Robbins Andrew R0001193125-26-234578
SEC(opens sec.gov)
Dec 194
Robbins Andrew R0001193125-25-326775
SEC(opens sec.gov)
Jan 274
Robbins Andrew R0000950170-25-009257
SEC(opens sec.gov)
Mar 114
Robbins Andrew R0000950170-24-029433
SEC(opens sec.gov)
Jan 254
Robbins Andrew R0000950170-24-007414
SEC(opens sec.gov)
Nov 284
Robbins Andrew R0001209191-23-056798
SEC(opens sec.gov)
Jun 234
Robbins Andrew R0001209191-23-039420
SEC(opens sec.gov)
Feb 154
Robbins Andrew R0000899243-23-005135
SEC(opens sec.gov)
Jun 244
Robbins Andrew R0001209191-22-039328
SEC(opens sec.gov)
Jan 274
Robbins Andrew R0000899243-22-003462
SEC(opens sec.gov)
May 144/A
Robbins Andrew R0001209191-21-032965
SEC(opens sec.gov)
May 74
Robbins Andrew R0001209191-21-031108
SEC(opens sec.gov)
Feb 124
Robbins Andrew R0000899243-21-006403
SEC(opens sec.gov)
Dec 94
Robbins Andrew R0000899243-20-033232
SEC(opens sec.gov)

Companies

Address

C/O COGENT BIOSCIENCES, INC. 180 THIRD AVENUE, 4TH FLOOR

WALTHAM, MA, 02451